当前位置: 首页 > 期刊 > 《医学信息》 > 2018年第15期
编号:13306710
蛋白磷酸酶1和2A的研究进展(5)
http://www.100md.com 2018年4月16日 《医学信息》 2018年第15期
     [18]Arroyo JD,Hahn WC.Involvement of PP2A in viral and cellular transformation [J].Oncogene,2005,24(52):7746.

    [19]Chen HF,Mai JR,Wan JX,et al.Role of a Novel Functional Variant in the PPP2R1A Promoter on the Regulation of PP2A-Aalpha and the Risk of Hepatocellular Carcinoma[J].Plos One,2013,8(3):e59574.

    [20]Jeong AL,Yang Y.PP2A function toward mitotic kinases and substratesduring the cell cycle[J].Bmb Reports,2013,46(6):289-294.

    [21]于丽凤,赵美咪.蛋白磷酸酶参与豚鼠心肌L-型钙通道run-down机制的研究[A].中国生理学会心血管生理学术会议论文集[C].2013.

    [22]Rossi D,Sorrentino V.Molecular genetics of ryanodine receptors Ca2+release channels [J].Cell Calcium,2002,32(5-6):307-319.

    [23]Grote-Wessels S,Baba HA,Boknik P,et al.Inhibition of protein phosphatase 1 by inhibitor-2 exacerbates progression of cardiac failure in a model with pressure overload [J].Cardiovasc Res,2008,79(3):464-471.

    [24]Kiss E,Jakab G,Krani E,et al.Thyroid homone induced alterations in phospholamban protein expression.Regulatory effects on sarcoplasmic reticulum Ca2+transport and myocardial mlaxation [J].Circ Res,1994,75(2):245-251.

    收稿日期:2018-5-27;修回日期:2018-6-7

    編辑/李桦, 百拇医药(张文慧 高丽 黄惠丽 谢铭 陈可塑 刘福明 陈龙 王荣荣)
上一页1 2 3 4 5